Alluzience, Injektionslösung
7680681450016
CH-68145
Injektionslösung
Associated product:
ALLUZIENCE sol inj 125 U/0.625ml flac
1 / 2
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
complexus toxini botulinici A et haemagglutinini
|
125.0 U | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrium
|
2.156 MG | Substance | HBESI |
|
polysorbatum 80
|
- | Substance | HNIDK |
Authorization holder
IPSEN Pharma Schweiz GmbH
6300 Zug
Authorization information
- Swissmedic authorization number
- 68145
- Drug name
- Alluzience, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- M03AX01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 10/12/2021
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.13.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ALLUZIENCE sol inj 125 U/0.625ml flac
- Description (DE)
- ALLUZIENCE Inj Lös 125 E/0.625ml Durchstf
- Market launch
- 10/12/2021
- Narcotic (BTM)
- No
Other package sizes (1)
ALLUZIENCE sol inj 125 U/0.625ml flac 2 pce
2 DUR
GTIN: 7680681450023